FFAR2 and colonic neoplasm: Studies have shown that the number of butyrate-producing bacteria in colon cancer patients is significantly reduced, and the expression of receptors GPR43 and GPR109A is also reduced considerably, indicating that SCFAs have a protective effect on colitis and colon cancer (189).